Biomea Fusion, Inc. (BMEA)

NASDAQ: BMEA · Real-Time Price · USD

1.810

-0.180 (-9.05%)

At close: Jun 27, 2025, 4:00 PM

1.840

+0.030 (1.66%)

After-hours: Jun 27, 2025, 6:36 PM EDT

Biomea Fusion Employees

Biomea Fusion had 106 employees as of December 31, 2024. The number of employees increased by 3 or 2.91% compared to the previous year.

Employees

106

Change (1Y)

3

Growth (1Y)

2.91%

Revenue / Employee

n/a

Profits / Employee

-$1,213,462

Market Cap

68.01M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	106	3	2.91%
Dec 31, 2023	103	20	24.10%
Dec 31, 2022	83	32	62.75%
Dec 31, 2021	51	39	325.00%
Dec 31, 2020	12	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

BMEA News

5 days ago - Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) - GlobeNewsWire
10 days ago - Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates - GlobeNewsWire
10 days ago - Biomea Fusion Shares Fall After Pricing Underwritten Public Offering - Market Watch
10 days ago - Biomea Fusion Announces Pricing of Public Offering of Securities - GlobeNewsWire
10 days ago - Stocks to Watch: Biomea Fusion, Bitdeer Technologies - Market Watch
10 days ago - Biomea Fusion Announces Proposed Public Offering of Securities - GlobeNewsWire
15 days ago - Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025 - GlobeNewsWire
6 weeks ago - Biomea Fusion's BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia - GlobeNewsWire